Reproductive Medicine

A topic in the Science corpus, drawn from 1,053 papers.

Trusted voices in Reproductive Medicine

Ordered by the trust Reproductive Medicine's own network concentrates on each researcher, most first.

  1. R. Buchholz — trusted by 67 researchers here
  2. G. Herek — trusted by 33 researchers here
  3. A. D’augelli — trusted by 20 researchers here
  4. L. Kurdek — trusted by 23 researchers here
  5. C. Patterson — trusted by 16 researchers here
  6. Philip Ball — trusted by 12 researchers here
  7. Markus P. Bidell — trusted by 9 researchers here
  8. W. Fabricius — trusted by 10 researchers here
  9. Ç. Gerçel-Taylor — trusted by 14 researchers here
  10. D. Taylor — trusted by 14 researchers here
  11. F. Marlowe — trusted by 11 researchers here
  12. Amy L. Hequembourg — trusted by 8 researchers here

Most-cited papers in Reproductive Medicine

Ordered by the recorded citation count from the source corpus; a citation is not an endorsement.

  1. Publisher's Note (2003) — 287,289 citations
  2. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome (PCOS). (2004, Human Reproduction) — 8,538 citations
  3. Integrated Genomic Analyses of Ovarian Carcinoma (2011, Nature) — 7,559 citations
  4. Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. (2004, Fertility and Sterility) — 5,680 citations
  5. Integrated Genomic Characterization of Endometrial Carcinoma (2013, Nature) — 5,292 citations
  6. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic floor dysfunction (2010, International Urogynecology Journal) — 4,842 citations
  7. Polycystic ovary syndrome (2016, Nature Reviews Disease Primers) — 4,774 citations
  8. Publisher's Note (2017, Neuroscience and Biobehavioral Reviews) — 4,705 citations
  9. Average risks of breast and ovarian cancer associated with BRCA1 or BRCA2 mutations detected in case Series unselected for family history: a combined analysis of 22 studies. (2003, American Journal of Human Genetics) — 3,796 citations
  10. The need for a new medical model: a challenge for biomedicine. (2012, Psychodynamic Psychiatry) — 3,787 citations
  11. Declaration of Helsinki. Ethical Principles for Medical Research Involving Human Subjects (2009, Journal of the Indian Medical Association) — 3,694 citations
  12. Elective single-embryo transfer versus double-embryo transfer in in vitro fertilization (2004, New England Journal of Medicine) — 3,665 citations
  13. Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. (2009, New England Journal of Medicine) — 3,580 citations
  14. Intratumoral T cells, recurrence, and survival in epithelial ovarian cancer. (2003, New England Journal of Medicine) — 3,391 citations
  15. Standards of Care for the Health of Transsexual, Transgender, and Gender-Nonconforming People, Version 7 (2012) — 3,084 citations
  16. Ovarian Cancer Statistics, 2018 (2018, Ca) — 3,060 citations
  17. The oxytocin receptor system: structure, function, and regulation. (2001, Physiological Reviews) — 2,972 citations
  18. The Health of Lesbian, Gay, Bisexual, and Transgender People: Building a Foundation for Better Understanding (2011) — 2,758 citations
  19. World Health Organization reference values for human semen characteristics. (2010, Human Reproduction Update) — 2,683 citations
  20. Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome (2018, Clinical Endocrinology) — 2,461 citations
  21. Prolactin: structure, function, and regulation of secretion. (2000, Physiological Reviews) — 2,429 citations
  22. International estimates of infertility prevalence and treatment-seeking: potential need and demand for infertility medical care. (2007, Human Reproduction) — 2,406 citations
  23. Revised FIGO staging for carcinoma of the vulva, cervix, and endometrium (2009) — 2,389 citations
  24. Maintenance Olaparib in Patients with Newly Diagnosed Advanced Ovarian Cancer (2018, New England Journal of Medicine) — 2,381 citations
  25. Neoadjuvant chemotherapy or primary surgery in stage IIIC or IV ovarian cancer. (2010, New England Journal of Medicine) — 2,377 citations
  26. MicroRNA signatures of tumor-derived exosomes as diagnostic biomarkers of ovarian cancer. (2008, Gynecologic Oncology) — 2,343 citations
  27. High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. (2003, American Journal of Obstetrics and Gynecology) — 2,316 citations
  28. Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54 (2003, Proceedings of the National Academy of Sciences of the United States of America) — 2,310 citations
  29. Incorporation of bevacizumab in the primary treatment of ovarian cancer. (2011, New England Journal of Medicine) — 2,288 citations
  30. Executive summary of the Stages of Reproductive Aging Workshop + 10: addressing the unfinished agenda of staging reproductive aging (2012, Menopause) — 2,286 citations
  31. Nature Communications (2010) — 2,248 citations
  32. Men at risk: occupation and male infertility. (2004, Fertility and Sterility) — 2,209 citations
  33. Supplemental digital content. (2013, Health Physics) — 2,192 citations
  34. National, Regional, and Global Trends in Infertility Prevalence Since 1990: A Systematic Analysis of 277 Health Surveys (2012, PLoS Medicine) — 2,158 citations
  35. A unique view on male infertility around the globe (2015, Reproductive Biology and Endocrinology) — 2,134 citations
  36. Niraparib Maintenance Therapy in Platinum-Sensitive, Recurrent Ovarian Cancer. (2016, New England Journal of Medicine) — 2,122 citations
  37. Breast and Ovarian Cancer Risks Due to Inherited Mutations in BRCA1 and BRCA2 (2003, Science) — 2,115 citations
  38. Survival effect of maximal cytoreductive surgery for advanced ovarian carcinoma during the platinum era: a meta-analysis. (2002, Journal of Clinical Oncology) — 2,079 citations
  39. Climate of change. (2008, Nursing Standard) — 2,068 citations
  40. Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study. (2003, Journal of Clinical Oncology) — 2,032 citations
  41. The Androgen Excess and PCOS Society criteria for the polycystic ovary syndrome: the complete task force report. (2009, Fertility and Sterility) — 2,022 citations
  42. A phase 3 trial of bevacizumab in ovarian cancer. (2011, New England Journal of Medicine) — 2,021 citations
  43. ESHRE guideline: management of women with endometriosis. (2014, Human Reproduction) — 1,979 citations
  44. A conceptual framework for clinical work with transgender and gender nonconforming clients: An adaptation of the Minority Stress Model. (2012) — 1,960 citations
  45. American Society of Clinical Oncology recommendations on fertility preservation in cancer patients. (2006, Journal of Clinical Oncology) — 1,955 citations
  46. Fertility and infertility: Definition and epidemiology. (2018, Clinical Biochemistry) — 1,940 citations
  47. Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline. (2006, Journal of Clinical Endocrinology and Metabolism) — 1,909 citations
  48. Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial. (2010, The Lancet) — 1,894 citations
  49. The Origin and Pathogenesis of Epithelial Ovarian Cancer- a Proposed Unifying Theory (2010, American Journal of Surgical Pathology) — 1,864 citations
  50. The complex role of estrogens in inflammation. (2007, Endocrine reviews) — 1,859 citations

Most active researchers

By papers in this topic: a volume measure, not trust.